Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y604) antibody (ab61791)

Publishing research using ab61791? Please let us know so that we can cite the reference in this datasheet.

ab61791 has been referenced in 8 publications.

  • Mimche PN  et al. EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells. Sci Rep 8:2532 (2018). IHC-Fr . PubMed: 29416088
  • Clements MP  et al. The Wound Microenvironment Reprograms Schwann Cells to Invasive Mesenchymal-like Cells to Drive Peripheral Nerve Regeneration. Neuron 96:98-114.e7 (2017). WB . PubMed: 28957681
  • Ojosnegros S  et al. Eph-ephrin signaling modulated by polymerization and condensation of receptors. Proc Natl Acad Sci U S A 114:13188-13193 (2017). PubMed: 29192024
  • Jungas T  et al. Eph-mediated tyrosine phosphorylation of citron kinase controls abscission. J Cell Biol 214:555-69 (2016). WB, ICC/IF . PubMed: 27551053
  • Gong J  et al. Exosomes mediate cell contact-independent ephrin-Eph signaling during axon guidance. J Cell Biol 214:35-44 (2016). PubMed: 27354374
  • Krusche B  et al. EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells. Elife 5:N/A (2016). PubMed: 27350048
  • Wilson C  et al. Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition. Oncotarget 5:7328-41 (2014). WB ; Human . PubMed: 25193862
  • Ottone C  et al. Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells. Nat Cell Biol 16:1045-56 (2014). IHC . PubMed: 25283993

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
For licensing inquiries, please contact partnerships@abcam.com

Sign up